WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 46'0821 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 1'377  1'362  1'349  1'334  1'306  667  496  360 
Births 20  20  20  20  20  14  14  12 
Surviving infants 20  20  20  20  20  14  14  11 
Pop. less than 5 years 109  107  104  99  94  72  66  50 
Pop. less than 15 years 296  289  281  273  263  205  162  124 
Female 15-49 years 309  309  309  309  306  162  113  75 

Number of reported cases

(Click for retrospective incidence data for Bahrain)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  46  59  1'861 
Mumps
ChartChart
  36  21  59  29  18  167 
Pertussis
ChartChart
  106 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bahrain)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  87  73  63 
DTP1 1994  99     82  98  98  99  99*  99  98 
DTP3 1994  90     82  98  99  99  99  99*  97  94  92 
DTP4          98  99* 
IPV1          98  98 
HepB_BD          99  99*  99  99*  99* 
HepB3 1994  88     82  98  99  99  99  99*  97 
Hib3          98  99  99  99  99*  97 
JapEnc         
MCV1          99*  99*  99*  99*  99*  98  87  63 
MCV2          99*  99*  99*  99*  96  92 
PCV1          99  99  99*  99*  99* 
PCV3          98  98  99*  99  99* 
Pol3 1994  90     82  98  99  99  99  99*  97  94  92 
Rota1          97  98  98  99  97 
RotaC          97  97  97  96  96 
Rubella1          99*  99*  99*  99* 
TT2plus          41  30  38  36  40  71  41 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bahrain)
DTP1
ChartChart
  99  99  99  99  98  97  89 
DTP3
ChartChart
  99  99  99  99  97  94  72 
HepB3
ChartChart
  99  99  99  99  97 
HepB_BD
ChartChart
 
Hib3
ChartChart
  99  99  99  99  97 
MCV1
ChartChart
  99  99  99  99  98  87  45 
MCV2
ChartChart
  99  99  99  96  92 
PAB
ChartChart
  98  94  94  94  84  48 
PCV3
ChartChart
  98  99  99  99 
Pol3
ChartChart
  99  99  99  99  97  94  72 
RotaC
ChartChart
  97  97  96  96 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; No infants born to parents originally from TB endemic area
DT 2, 4, 6, 18 months; 5 years; Yes Children with contraindications or allergic to Pertussis componant of the vaccine
DTaP 5 years; Yes Preschool vaccination
DTaPHibHepIPV 2, 4 months; Yes Second dose of this vaccine was added at the age of 4 months starting from May 2015, replacing pentavalent at age of 4 months.
DTwPHib 18 months; Yes Routine childhood vaccination starting from May 2015, prior to May 2015 pentavalent was given at 18 months vaccination.
DTwPHibHepB 6 months; Yes This vaccine was given also at age of 4 and 18 months, however since May 2015 its is given only at age of 6 months. 4 months dose replaced by hexavalent and 18 months by tetravalent.
HIB > 5 years; Yes Given as single dose for >5 years children with sickle cell disease, anatomical and/or surgical asplenia, post bone marrow transplant & certain cancer after finishing treatment;
HPV Yes available only in the private sector
HepA 15 months; 2 years; Yes The first dose of Hep A vaccine was given at the age of 18 months before May 2015, however the age brought earlier to 15 months. Catch-up campaign for school students at age of 12 & 13 yrs
HepB_Adult x3 doses; Yes High risk groups ,certain occupations at risk including HCW, college students & others.
HepB_Pediatric birth; 1 month; Yes Routine universal hepatitis B birth dose started from May 2015, second dose at 1 month given to infant of Hep B positive mothers.
IPV 2, 4, 6, 18 months; 4-5 years; Yes For immunocompromized and their household members
Influenza Children; elderly; risk groups Yes and healthcare workers, obese, residents of nursing homes& other long term facilities , household of high risks of flu complications, offered to any one requesting the vaccine
MMR 12, 18 months; Yes The second dose of MMR vaccine is given at 18 months starting from May 2015 replacing the preschool at age of 4-5 years. Also, it is given for non-immune women at reproductive age group
MenACWY 2 years; Yes Also given to high risk groups and to travelers to Holly places, meningitis belt countries and countries reporting outbreak.
OPV 4, 6, 18 months; 4-5 years; Yes traveller to polio endemic countries
Pneumo_conj 2, 4, 6, 15 months; Yes as a single dose for those at 50 years of age and above
Pneumo_ps >=65 years; Yes routinely for those at age of 65 yrs and above & High Risk Groups from age of 2 years and above
Rotavirus 2, 4 months; Yes
Td >7 years; Yes Pregnant women, Post trauma, certain occupations at risk &Haj pilgrims, others at risk of exposure
Tdap 13 years; Yes School students Vaccination, elderly and other at risk.
Typhoid Yes Travellers, certain occupations at risk
Varicella 1, 3 years; Yes Also, the vaccine is given to high risk groups including HCW at direct patient care, household of oncology patient and others
YF Yes Travellers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2013-2015  2012-2015      2006-2012   
Nº of districts with microplans that include activities to raise immunization coverage number      

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100    100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100    100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100        100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.